Publication:
The predictors of remission in major depressive disorder

dc.contributor.buuauthorAkkaya, Cengiz
dc.contributor.buuauthorEker, Salih Saygın
dc.contributor.buuauthorSarandöl, Aslı
dc.contributor.buuauthorCangür, Şengül
dc.contributor.buuauthorKirli, Selçuk
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPsikiyatri Ana Bilim Dalı
dc.contributor.departmentBiyoistatistik Ana Bilim Dalı
dc.contributor.researcheridEKJ-8427-2022
dc.contributor.researcheridQ-9477-2019
dc.contributor.researcheridFVU-6404-2022
dc.contributor.researcheridJHH-9596-2023
dc.contributor.researcheridCZU-1387-2022
dc.contributor.scopusid14061855100
dc.contributor.scopusid36341064200
dc.contributor.scopusid14020405100
dc.contributor.scopusid8604063700
dc.contributor.scopusid14019745700
dc.date.accessioned2024-04-02T05:25:34Z
dc.date.available2024-04-02T05:25:34Z
dc.date.issued2013
dc.description.abstractBackground: We aimed to determine the predictors of remission in major depressive disorder (MDD) with antidepressant treatment (AT). Methods: The subjects were recruited from the databases of the previous four studies. 178 patients were separated in to two groups at the final visit regarding remission. The patients were analyzed in terms of sociodemographic and clinical features regardless of their AT. Results: The difference in sociodemographic and clinical features was insignificant between the groups. Remitted patients had lower scores on the Hamilton Depression Rating Scale (HDRS), Montgomery-Asberg Depression Scale, Hamilton Anxiety Rating Scale, and the Clinical Global Impression Scale compared to baseline whereas Social Adaptation Self-evaluation Scale (SASS) scores were higher. To evaluate the impact of basal scores of HDRS and SASS on non remission rates, logistic regression analysis was performed. The analysis result was significant (p<0.001). Valid classification rate was 66% for this model. For this model, the scores of HDRS and SASS at visit 1 are significant risk factors for non-remission (p<0.001). As the value of HDRS increases, the risk of non-remission increases 1.095 fold (Odds ratio 95%, confidence interval: 1.045-1.147), whereas as the value of SASS decreases the risk of non-remission increases 1, 076 fold (Odds ratio 95%, confidence interval: 1.042-1.114). For each patient non-remission possibility can be predicted by "p(non remission)=1/[(1+exp (-0, 093xV1HDRS+0, 075xV1SASS)]" equivalent via this model. Conclusion: The findings of the present study suggest that severe level of depression, anxiety and social maladaptation at baseline are more likely to predict remission.
dc.identifier.citationZengin, S. (2013). “The predictors of remission in major depressive disorder”. Noropsikiyatri Arsivi, 50(2), 122-129.
dc.identifier.doihttps://doi.org/10.4274/npa.y6279
dc.identifier.endpage129
dc.identifier.issn1300-0667
dc.identifier.issn1309-4866
dc.identifier.issue2
dc.identifier.scopus2-s2.0-84878930305
dc.identifier.startpage122
dc.identifier.urihttps://hdl.handle.net/11452/40896
dc.identifier.volume50
dc.identifier.wos000320972700005
dc.indexed.scopusScopus
dc.indexed.trdizinTRDizin
dc.indexed.wosSCIE
dc.language.isoen
dc.relation.journalTürk Nöropsikiyatri Derneği
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNeurosciences & neurology
dc.subjectMajor depressive disorder
dc.subjectRemission
dc.subjectAntidepressant
dc.subjectPost-hoc analysis
dc.subjectClinical predictors
dc.subjectTreatment response
dc.subjectFamily-history
dc.subjectRating-scale
dc.subjectDouble-blind
dc.subjectEfficacy
dc.subjectSertraline
dc.subjectTolerability
dc.subject.emtreeAntidepressant agent
dc.subject.emtreeAnxiety
dc.subject.emtreeArticle
dc.subject.emtreeClinical feature
dc.subject.emtreeClinical Global Impression scale
dc.subject.emtreeConsultation
dc.subject.emtreeControlled study
dc.subject.emtreeDemography
dc.subject.emtreeDisease severity
dc.subject.emtreeHamilton Anxiety Scale
dc.subject.emtreeHamilton scale
dc.subject.emtreeHuman
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMajor depression
dc.subject.emtreeMaladjustment
dc.subject.emtreeMontgomery Asberg Depression Rating Scale
dc.subject.emtreePrediction
dc.subject.emtreePsychological rating scale
dc.subject.emtreeRemission
dc.subject.emtreeRisk factor
dc.subject.emtreeSocial Adaptation Self evaluation Scale
dc.subject.emtreeSocial status
dc.subject.scopusMorpholines; Reboxetine; Amino Alcohols
dc.subject.wosClinical neurology
dc.titleThe predictors of remission in major depressive disorder
dc.title.alternativeMajör depresif bozuklukta düzelmenin öngörücüleri
dc.typeArticle
dc.wos.quartileN/A
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Psikiyatri Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Biyoistatistik Ana Bilim Dalı
local.indexed.atTrDizin
local.indexed.atWOS
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: